COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04527211

Eduar D. Echeverri, Dr.

echeverri.eduar@javeriana.edu.co

2020-08-26

Unknown

RCT

Randomized

Parallel

Blind label

single-center

Prevention

inclusion criteria: - subjects over 18 years old of any sex who work as health care workers, laboriously active during the recruitment of the study in health services that do not screen for the exclusion of acutely ill patients. - subjects who have not presented general symptoms such as general discomfort, fever, cough, dyspnoea or muscle pain in the last week. - subjects with negative covid-19 serological antibody diagnostic tests.

- subjects considered as a resolved case of covid-19 infection, according to guidelines from the colombian national institute of health. - health personnel with social distancing due to close contact without personal protective equipment with confirmed patients of infection, or who are taking any medication as possible prophylaxis for covid-19 (example; chloroquine, hydroxychloroquine, azithromycin) - health workers who have permits or temporary withdrawal from their hospital work for more than one week during the first month of the study. - subjects with known allergy to ivermectin. - women in a state of pregnancy or lactation. - |subjects with a body mass index less than 18.5 and greater than 35.

2

Javeriana University

18

100

Colombia

Health workers

N/A

550

Clinical development of covid-19 disease during the intervention period

None

Phase 3

[{"arm_notes": "", "treatment_id": 693, "treatment_name": "Ivermectin", "treatment_type": "Antiparasitics", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]